XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Unaudited Condensed Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Cumulative Translation Adjustments
Beginning balance (in shares) at Dec. 31, 2020   61,881      
Beginning balance at Dec. 31, 2020 $ 16,424 $ 62 $ 158,190 $ (141,825) $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering costs (in shares)   3,846      
Issuance of common stock, net of offering costs 24,871 $ 4 24,867    
Issuance of common stock resulting from the exercise of stock options (in shares)   1,975      
Issuance of common stock resulting from the exercise of stock options 8,633 $ 2 8,631    
Share-based compensation 1,284   1,284    
Translation adjustment 1       1
Net loss (7,381)     (7,381)  
Ending balance (in shares) at Mar. 31, 2021   67,702      
Ending balance at Mar. 31, 2021 43,832 $ 68 192,972 (149,206) (2)
Beginning balance (in shares) at Dec. 31, 2021   68,126      
Beginning balance at Dec. 31, 2021 31,727 $ 68 200,614 (168,953) (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of restricted stock (in shares)   23      
Share-based compensation 1,888   1,888    
Translation adjustment 2       2
Net loss (7,740)     (7,740)  
Ending balance (in shares) at Mar. 31, 2022   68,149      
Ending balance at Mar. 31, 2022 $ 25,877 $ 68 $ 202,502 $ (176,693) $ 0